DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,985,386 | -66.4% | 798,701 | -65.6% | 0.22% | -74.5% |
| Q1 2023 | $26,753,864 | -0.6% | 2,322,384 | 0.0% | 0.86% | +5.3% |
| Q4 2022 | $26,916,431 | +1722.4% | 2,322,384 | +980.2% | 0.82% | +1505.9% |
| Q2 2022 | $1,477,000 | -28.8% | 215,000 | 0.0% | 0.05% | -21.5% |
| Q1 2022 | $2,073,000 | -18.9% | 215,000 | 0.0% | 0.06% | -19.8% |
| Q4 2021 | $2,556,000 | -28.4% | 215,000 | 0.0% | 0.08% | -34.7% |
| Q3 2021 | $3,569,000 | -21.1% | 215,000 | 0.0% | 0.12% | -26.6% |
| Q2 2021 | $4,524,000 | +35.5% | 215,000 | 0.0% | 0.17% | +14.2% |
| Q1 2021 | $3,339,000 | -26.0% | 215,000 | 0.0% | 0.15% | -39.1% |
| Q4 2020 | $4,515,000 | +4.0% | 215,000 | 0.0% | 0.24% | -21.6% |
| Q3 2020 | $4,341,000 | – | 215,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |